Tech Company Financing Transactions
Bryn Pharma Funding Round
Bryn Pharma closed a $17.5 million financing round on 10/25/2019. Backers included private investors.
Transaction Overview
Company Name
Announced On
10/25/2019
Transaction Type
Venture Equity
Amount
$17,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for U.S. approval and to preparation for commercialization of BRYN-NDS1C, its bidose epinephrine nasal spray.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7101 Millstone Ridge Ct.
Raleigh, NC 27614
USA
Raleigh, NC 27614
USA
Phone
Website
Email Address
Overview
Bryn Pharma was founded by patients who are personally affected by anaphylaxis. The concerns of patients and caregivers like us have informed our approach. Our experience has fueled our drive to find A Better Way. We are creating a practical solution to help our community better manage their daily lives with severe allergies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Dworaczyk
Chief Financial Officer
Dale Sander
Co-Founder
Michelle Lobel
President
Steven Hartman
VP - Bus. Development
Stephen Beckman
Browse more venture capital transactions:
Prev: 10/25/2019: Modern Animal venture capital transaction
Next: 10/25/2019: Gallant venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs